Alergotest s.c., Specjalistyczne Centrum Medyczne Andrzej Emeryk, Malgorzata Bartkowiak-Emeryk
- Address
- Jana Sapiehy 2 lok. 4A, 20-095 Lublin, Poland
Immune System Diseases
A pediatric study at Alergotest s.c. investigates the effectiveness of a 10 mg orally disintegrating tablet of bilastine for children aged 6‑12 with allergic rhinoconjunctivitis.
- Evaluation of symptom reduction using a five‑symptom score
- Assessment of safety and tolerability in a short‑term regimen
- Impact on daily quality of life for young patients
The research aims to provide a convenient, fast‑acting option for seasonal allergy relief while gathering data on real‑world effectiveness.
Respiratory Tract Diseases
A double‑blind trial conducted by investigators at Specjalistyczne Centrum Medyczne Andrzej Emeryk compares a high‑dose fluticasone propionate/albuterol inhaler with albuterol alone for rescue treatment in adults with asthma.
- Measurement of severe adverse events during rescue use
- Comparison of integrated electronic inhaler module versus standard device
- Analysis of lung function improvement and symptom control
The study seeks to determine whether combining an anti‑inflammatory steroid with a bronchodilator reduces emergency episodes and enhances overall asthma management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alergotest s.c., Specjalistyczne Centrum Medyczne Andrzej Emeryk, Malgorzata Bartkowiak-Emeryk
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Fluticasone Propionate/Salbutamol Sulfate in Reducing Severe Asthma Exacerbations in Asthma Patients | Teva Branded Pharmaceutical Products R&D LLC | Phase III | Not Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bilastine | 1 | Unknown | 2026-03-30 | 2026-03-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.